Five-Year Results of a Randomized Trial Comparing De Novo Sirolimus and Cyclosporine in Renal Transplantation: The Spiesser Study
American Journal of Transplantation, 04/06/2012
Lebranchu Y et al. – Results confirmed the high sirolimus discontinuation rate due to adverse events. Nevertheless, a benefit was evidenced on renal function in patients still on treatment at 5 years.